Persistent sterile injectable drugs shortages put patients at risk
Hospitals experiencing a shortage of generic sterile injectable drugs will likely see a spike in their mortality rates, according to a new study.
More From Around the Web
Check out these Articles
- Pope speaks broadly about religious freedom, human life at every stage
- HHS stonewalls on King v. Burwell, releases sign-up numbers
- Providers say they’ll campaign against cuts to colonoscopy payments
- House postpones coming votes, cites snow storm
- Extremely sick newcomers, risk-corridor shortfalls sink co-op plans
- Jean Barrett Blake named UH chief nursing officer at University Hospitals
- Speaker Ryan vows to ‘replace every word of ACA’
- Kentucky elects Republican governor committed to ACA rollback
- Licenses suspended at two abortion clinics in South Carolina
- CMS proposes expanding diabetes-prevention model
- Nearly 1 million enrolled in ACA coverage after open enrollment
- Two big health systems in the Bronx consider joining forces
- Medicare Advantage plans see 0.25% rate hike for 2018
- NIH releases potentially lifesaving blood pressure study results
- Majority of people would give personal information to Precision Medicine da...
- Virus affects Appalachian Regional Healthcare hospitals' computers in ...
- Advocates look within military community to help curb mental health provide...
- LabCorp earnings grow from Covance acquisition
- If you build the health app, will the Medicaid recipients come?
- Nevada officials to review group homes for mentally ill
- Court sides against FDA in ‘off-label’ drug promotion case